Suppliers / Smaart Pharmaceutticals

Smaart Pharmaceutticals

India 32 employees Updated 9 July 2026

Smaart Pharmaceutticals is an API manufacturer based in India. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Customs aggregates show $677K of exports covering 75 molecules to 20 destinations in 2025.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Chlorhexidine US FDA 1
Nebivolol US FDA 1

Also appears on these molecule pages

Chlorhexidine API Nebivolol API

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $238K 11
2025 Not reported $677K 20
2024 Not reported $524K 18
2023 Not reported $811K 21

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Smaart Pharmaceutticals

Does Smaart Pharmaceutticals hold a US DMF or a CEP?
Smaart Pharmaceutticals holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Smaart Pharmaceutticals make?
2 molecules are on record against Smaart Pharmaceutticals, including Chlorhexidine and Nebivolol. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Smaart Pharmaceutticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Cadila Pharmaceuticals shares 2 molecules Hetero shares 1 molecule Macleods Pharmaceuticals shares 1 molecule Zhejiang Huahai Pharmaceutical shares 1 molecule Honour Lab shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts